Bosentan Tablets IP 62.5 mg

Get a Price/Quote

Bosentan Tablets IP 62.5 mg Specification

Life Span
Refer to expiry date on packaging (generally 24-36 months from manufacturing)

Brand Name
Bosentan-62.5

Packaging Type
Blister pack or box

Indication
Pulmonary arterial hypertension (PAH)

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
Common pack sizes: 10 and 30 tablets

Salt Composition
Bosentan 62.5 mg

Origin of Medicine
Manufactured in India

Drug Type
Prescription medicine

Ingredients
Bosentan

Physical Form
Tablet

Function
Vasodilator - improves blood flow by blocking endothelin receptors

Recommended For
Treatment of pulmonary arterial hypertension (PAH)

Dosage
62.5 mg per tablet, dosage as prescribed by physician

Dosage Guidelines
Follow prescribed regimen by healthcare professional

Suitable For
Adults

Quantity
As per pack size, commonly 10 or 30 tablets per box

Storage Instructions
Store in a cool and dry place, below 25C, protect from light and moisture

Country of Export
Available for export to multiple countries (Canada, EU, UK, USA, Australia) as indicated by image

Therapeutic Class
Endothelin receptor antagonist

Route of Administration
Oral

Side Effects
Headache, liver enzyme elevation, edema, anemia, respiratory tract infection

Patient Advice
Not for pediatric use unless prescribed by doctor; regular monitoring of liver function advised

Color
Film-coated tablet (specific color may vary)

Caution
Not to be used in pregnancy or severe liver impairment (consult healthcare provider)

Regulatory Approvals
Complies with Indian Pharmacopeia (IP)

Prescription/Non Prescription
Prescription

Bosentan Tablets IP 62.5 mg About

Bosentan Tablets IP 62.5 mg (brand name: Bosentan-62.5) is a laureate medicine in the class of endothelin receptor antagonists, marvelously sought-after for managing pulmonary arterial hypertension (PAH). These fresh, film-coated tablets are offered at a special rate as part of a clearance initiative for select buyers. The prescription-only product, manufactured in India, complies with Indian Pharmacopeia standards and is available for export to countries including Canada, EU, UK, USA, and Australia. Bosentan-62.5 ensures superior function as a vasodilator, enhancing blood flow by selectively blocking endothelin receptors. Careful patient monitoring is advised due to potential side effects such as elevated liver enzymes, headache, or edema. Not suitable during pregnancy or for pediatric use unless instructed by a healthcare provider.

Bosentan Tablets IP 62.5 mg: Usage & Applications

Bosentan Tablets IP 62.5 mg, marvelously designed for adults, is primarily used for the treatment of pulmonary arterial hypertension (PAH). This sought-after film-coated tablet improves blood flow by binding endothelin receptors, thus functioning as a potent vasodilator. Bosentan-62.5 is prescribed under careful medical guidance and is not recommended for pediatric use unless directed by a doctor. The product's robust packaging and special clearance rates make it an exceptional choice for healthcare facilities and global suppliers seeking reliable PAH management solutions.

Bosentan Tablets IP 62.5 mg: Sample Policy & Supply Ability

Bosentan-62.5 is offered with a thoughtful sample policy, allowing potential clients to assess its laureate quality before bulk purchase. We ensure marvelous supply ability, efficiently meeting bulk and recurring demands, whether for 10 or 30 tablet packs. Shipments are dispatched promptly from our Indian facility via major FOB ports, ensuring products remain fresh and arrive securely packaged. Special rates on select orders further enhance value, making this clearance offer attractive for traders and healthcare distributors worldwide.

FAQ's of Bosentan Tablets IP 62.5 mg:

Q: What is the primary use of Bosentan Tablets IP 62.5 mg?

A: Bosentan Tablets IP 62.5 mg is mainly used in the treatment of pulmonary arterial hypertension (PAH), a condition that affects blood flow in the lungs, by acting as a vasodilator to improve circulation.

Q: How should Bosentan Tablets IP 62.5 mg be administered?

A: The medicine should be taken orally as prescribed by your healthcare provider. Follow the recommended dosage and timing, and never adjust the regimen without consulting a doctor.

Q: What precautions should I take while using Bosentan-62.5?

A: Regular liver function monitoring is advised. The medication is not suitable for pregnant individuals, patients with severe liver impairment, or pediatric patients unless explicitly prescribed.

Q: When should I avoid taking Bosentan Tablets?

A: You should avoid taking Bosentan-62.5 if you are pregnant, have severe liver impairment, or have been advised against its use by a healthcare professional.

Q: Where can Bosentan Tablets IP 62.5 mg be exported?

A: This product is available for export to multiple countries including Canada, the EU, UK, USA, and Australia, complying with Indian Pharmacopeia standards.

Q: What are the potential side effects of Bosentan-62.5?

A: Some commonly reported side effects include headache, edema, liver enzyme elevation, anemia, and respiratory tract infections. Consult a healthcare provider for detailed advice and regular monitoring.

Tell us about your requirement